Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465789 · ClinicalTrials.gov registry record
Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children
A clinical trial, sponsored by West Virginia School of Osteopathic Medicine.
- Terminated
- Registry status
- 33
- Enrollment target
NCT01465789: Clinical Trial study, sponsored by West Virginia School of Osteopathic Medicine.
NCT01465789 is a clinical trial that was terminated before completion, run by West Virginia School of Osteopathic Medicine. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01465789 was terminated before completion, sponsored by West Virginia School of Osteopathic Medicine.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to identify salivary biomarkers for monitoring cardiometabolic risk in children. The study hypothesis is that a combination of salivary biomarkers will predict the presence of risk factors including impaired fasting glucose, hypertension and dyslipidemia and will reflect changes in these risk factors over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-06 |
Why NCT01465789 stopped before completion
NCT01465789 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01465789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01465789 about?
NCT01465789 is a clinical study titled "Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children". The purpose of this study is to identify salivary biomarkers for monitoring cardiometabolic risk in children. The study hypothesis is that a combination of salivary biomarkers will predict the presence of risk factors including impaired fasting glucose, hypertension and dyslipidemia and will reflect...
What is the current status of trial NCT01465789?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2011-07. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01465789?
This trial is sponsored by West Virginia School of Osteopathic Medicine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia